logo
Share SHARE
FONT-SIZE Plus   Neg

CryoLife Agrees To Settle Patent Lawsuit With CardioFocus - Quick Facts

Medical devices company CryoLife Inc. (CRY) said Thursday it has entered into a settlement agreement with CardioFocus Inc.. The company said the agreement thereby brings to an end the outstanding patent dispute between its unit Cardiogenesis Corp. and CardioFocus pending in the U.S. District Court of Massachusetts.

As per the settlement terms, CryoLife has agreed to pay CardioFocus $4.5 million in cash within 30 days. Both parties have agreed to dismiss with prejudice all claims and counter claims associated with the lawsuit.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Nokia Corp. were gaining around 6 percent in mid-morning trading in Finland after the network equipment maker reported Thursday narrower loss in its first quarter. The company also reiterated its fiscal 2017 outlook for total cost savings. CEO Rajeev Suri said, "Overall, given Nokia's performance in the first quarter, I am optimistic about the year ahead, even if cautiously so." Aerospace and defense major Airbus Group SE reported Thursday higher profit and revenues in its first quarter with growth in all segments, except defence. Adjusted EBIT, a key earnings metric, meanwhile declined from last year. Looking ahead, for fiscal 2017, Airbus continues to expect mid-single-digit percentage growth in adjusted earnings per share and adjusted EBIT. Shares of AstraZeneca Plc were declining in the morning trading in London after the British drug giant reported Thursday weak profit and revenues in its first quarter, as product sales were hurt mainly by the residual impact of the US Crestor patent expiry. Core profit, however, increased with improved cost control. Further, the company confirmed its financial guidance for 2017.
comments powered by Disqus
RELATED NEWS
Trade CRY now with 
Follow RTT